Regulation of YY1, a Multifunctional Transcription Factor

Total Page:16

File Type:pdf, Size:1020Kb

Regulation of YY1, a Multifunctional Transcription Factor University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School 5-2001 Regulation of YY1, a Multifunctional Transcription Factor Ya-Li Yao University of South Florida Follow this and additional works at: https://scholarcommons.usf.edu/etd Part of the American Studies Commons Scholar Commons Citation Yao, Ya-Li, "Regulation of YY1, a Multifunctional Transcription Factor" (2001). Graduate Theses and Dissertations. https://scholarcommons.usf.edu/etd/1544 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Office of Graduate Studies University of South Florida Tampa, Florida CERTIFICATE OF APPROVAL __________________ Ph.D. Dissertation __________________ This is to certify that the Ph.D. Dissertation of YA-LI YAO with a major in Medical Sciences has been approved for the dissertation requirement on April 9, 2001 for the Doctor of Philosophy degree. Examining Committee: _________________________________________________ Major Professor : Edward Seto, Ph.D. _________________________________________________ Member : Burt Anderson, Ph.D. _________________________________________________ Member: Peter Medveczky, M.D. _________________________________________________ Member: Richard Jove, Ph.D. REGULATION OF YY1, A MULTIFUNCTIONAL TRANSCIPTION FACTOR by YA-LI YAO A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Medical Microbiology and Immunology College of Medicine University of South Florida May 2001 Major Professor: Edward Seto, Ph.D. DEDICATION To my parents, Ta-Chung (Righteous and Magnanimous) and Shiao-Hung (Little Rainbow). ACKNOWLEDGEMENTS I am eternally grateful to my Lord, Who gave me the chance to fulfill my dream of earning a Ph.D. degree. I would like to thank my mentor, Dr. Edward Seto, for his endless support and guidance. Without him I would never have accomplished my goal. My gratitude also extends to my committee members, who gave me invaluable advice and helped me meet the requirements of the department. My special acknowledgement goes to my husband, Dr. Wen-Ming Yang, whose help and encouragement accompanied me when I needed them the most. I thank Dr. Nancy Olashaw for critical reading and the core facilities at the Moffitt Cancer Center as well as the Protein Chemistry Core at the University of Florida for technical support. I would also like to express my gratitude to Kathy (Mom), Linda, Susan, Cheryl, Sally, and B.J. They made my life as a graduate student much easier and happier. TABLE OF CONTENTS LIST OF FIGURES iv ABSTRACT viii INTRODUCTION 1 Transcription is an important step in gene regulation. 1 Transcription in prokaryotes. 2 Transcription in eukaryotes. 3 RNA polymerase II and the eukaryotic promoter. 4 Activators and transcriptional activation. 6 Repressors and transcriptional repression. 8 Chromatin and transcription. 9 Chromatin remodeling. 10 Histone acetyltransferases as co-activators. 11 Histone deacetylases as co-repressors. 13 YY1 is a transcriptional regulator. 13 General characteristics of YY1. 14 YY1 and transcriptional initiation. 15 OBJECTIVES 17 MATERIALS AND METHODS 20 Isolation of YY1 genomic clones. 20 i Plasmids. 20 Sequencing of the human YY1 promoter. 22 Primer extension. 22 Cell line, transfection, luciferase assays, and CAT assays. 23 Recombinant proteins. 23 In vitro acetylation reactions. 24 Immunoprecipitation and western blot analysis. 24 In vitro protein-protein interaction assays. 25 Histone deacetylation assays. 25 Immunofluorescence analysis. 26 Electrophoretic mobility shift assays. 26 Gel filtration analysis of YY1. 27 Purification of a YY1 complex by anion exchange and immobilized- metal affinity chromatography. 27 Coomassie staining and silver staining. 27 Purification of a YY1 complex by anion exchange and antibody- affinity chromatography. 28 Purification of the F-YY1 complex. 28 Radioimmunoprecipitation analysis (RIPA) of F-YY1. 28 Accession number. 29 RESULTS 30 Determination of the transcriptional start site of the human YY1 gene. 30 ii Transcriptional analysis of the human YY1 promoter. 31 Sequence analysis of the human YY1 promoter. 33 E1A-mediated repression of the human YY1 promoter. 35 YY1 does not autoregulate its own promoter. 37 YY1 is acetylated by p300 and PCAF. 38 Lysine-to-arginine mutations within YY1 residues 170-200 significantly reduce the transcriptional repression activity of YY1. 45 Acetylation of YY1 residues 170-200 increases YY1 binding to HDACs. 46 HDAC1 and HDAC2 deacetylate YY1 170-200 but not the C- terminal region of YY1. 46 HDACs bind YY1 at multiple regions. 52 YY1 contains associated histone deacetylase activity, which localizes 52 to C-terminal residues 261-333 of YY1. Acetylation of YY1 at the C-terminal zinc finger domain decreases 54 the DNA-binding activity of YY1. YY1 exists in a high molecular weight protein complex. 57 Purification of native YY1 complexes. 57 Purification of a Flag-tagged YY1 complex. 65 DISCUSSION 70 REFERENCES 80 ABOUT THE AUTHOR End Page iii LIST OF FIGURES FIG. 1. Step-wise assembly of the transcriptional initiation complex. 5 FIG. 2. Regulation of transcription: a model. 7 FIG. 3. Determination of the 5’ end of the human YY1 transcript. 30 FIG. 4. Expression of luciferase enzymatic activity driven by the human YY1 promoter in transiently transfected cells. 32 FIG. 5A. DNA sequences upstream of the translational start codon of the human YY1 gene. 33 FIG. 5B. Comparison of the YY1 promoter DNA sequences between mouse and human. 34 FIG. 6. Adenovirus E1A proteins repress the YY1 promoter. 36 FIG. 7. The YY1 protein does not autoregulate the YY1 promoter. 37 FIG. 8. Multiple functional domains of transcription factor YY1. 38 FIG. 9A. Acetylation of YY1 by PCAF. 39 FIG. 9B. Acetylation of YY1 by p300. 40 FIG. 9C. Acetylation of YY1 is dependent on p300 or PCAF. 41 FIG. 9D. YY1 is acetylated in vivo. 42 FIG. 9E. Identification of regions of YY1 acetylated in vivo. 43 FIG. 9F, G. Determination of the number of acetylated lysines by mass spectrometry. 44 iv FIG. 10. The effect of acetylation of YY1 residues 170-200 on the transcriptional repressor activity of YY1. 45 FIG. 11. Increased HDAC-binding to YY1 residues 170-200 by acetylation. 47 FIG. 12A. YY1 peptide deacetylation by HDACs. 48 FIG. 12B. YY1 protein deacetylation by HDACs. 49 FIG. 12C. Deacetylation of YY1 serial deletion proteins by HDAC1. 50 FIG. 13. Mapping of the HDAC-interaction domains of YY1. 51 FIG. 14A. Histone deacetylase activity of endogenous YY1 in HeLa cells. 52 FIG. 14B, C. Identification of amino acid 261-333 as the histone deacetylase activity domain of YY1. 53 FIG. 14D. Expression of F-YY1 deletion mutants. 54 FIG. 14E. Sub-cellular localization of F-YY1 deletion constructs. 55 FIG. 15A, B. The effect of acetylation on YY1’s sequence-specific DNA- binding activity. 56 FIG. 16. Gel filtration analysis of YY1 in HeLa cells. 57 FIG. 17A, B. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and IMAC. (A) A Coomassie-stained SDS-polyacrylamide gel of the Q Sepharose fractions. (B) Western blot analysis of the Q Sepharose fractions. 58 FIG. 17C, D. Purification of a native YY1 complex from HeLa cells using v anion exchange chromatography and IMAC. (C). EMSA of the Q Sepharose fractions using the AAV P5+1 YY1 binding sequence as a probe. (D). Histone deacetylation assay of the Q Sepharose fractions. 59 FIG. 17E, F. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and IMAC. (E) Western blot analysis of the Ni2+ column fractions. (F) EMSA of the 300 mM imidazole-eluted fractions using the AAV P5+1 YY1 binding sequence as a probe. 60 FIG. 17G. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and IMAC. (G) Silver- staining analysis of the second fraction from the 300 mM imidazole-eluted fractions. 61 FIG. 18A, B. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and antibody-affinity chromatography. (A) A Coomassie-stained SDS- polyacrylamide gel of the Q Sepharose fractions. (B) Western blot analysis of the Q Sepharose fractions. 62 FIG. 18C, D. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and antibody-affinity chromatography. (C) EMSA of the Q Sepharose fractions using the AAV P5+1 YY1 binding sequence as a probe. (D) Histone deacetylation assay of the Q Sepharose fractions. 63 vi FIG. 18E. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and antibody-affinity chromatography: (E) Silver-staining analysis of fractions from the anti-YY1 H-10 column (lane 2) and the protein G control column (lane 1). 64 FIG. 18F. Purification of a native YY1 complex from HeLa cells using anion exchange chromatography and antibody-affinity chromatography. (F) Histone deacetylation assay from the protein G control column (protein G) and the anti-YY1 H-10 column (H-10) against the H4 peptide. 65 FIG. 19A. Silver-staining analysis of the second fractions from the Flag-alone (lane 1) column and the F-YY1 column (lane 2). 66 FIG. 19B. Histone deacetylation analysis of the second fractions from the Flag alone column and the F-YY1 column against the H4 peptide. 67 FIG. 20A. A representative autoradiograph showing proteins bound to Flag alone or F-YY1. 68 FIG. 20B. A representative autoradiograph showing proteins bound to different F-YY1. 69 FIG. 21 Summary of regulation of YY1 by acetylation and deacetylation. 72 vii REGULATION OF YY1, A MULTIFUNCTIONAL TRANSCRIPTIONAL FACTOR by YA-LI YAO An Abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Medical Microbiology and Immunology College of Medicine University of South Florida May 2001 Major Professor: Edward Seto, Ph.D.
Recommended publications
  • 2017.08.28 Anne Barry-Reidy Thesis Final.Pdf
    REGULATION OF BOVINE β-DEFENSIN EXPRESSION THIS THESIS IS SUBMITTED TO THE UNIVERSITY OF DUBLIN FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 2017 ANNE BARRY-REIDY SCHOOL OF BIOCHEMISTRY & IMMUNOLOGY TRINITY COLLEGE DUBLIN SUPERVISORS: PROF. CLIONA O’FARRELLY & DR. KIERAN MEADE TABLE OF CONTENTS DECLARATION ................................................................................................................................. vii ACKNOWLEDGEMENTS ................................................................................................................... viii ABBREVIATIONS ................................................................................................................................ix LIST OF FIGURES............................................................................................................................. xiii LIST OF TABLES .............................................................................................................................. xvii ABSTRACT ........................................................................................................................................xix Chapter 1 Introduction ........................................................................................................ 1 1.1 Antimicrobial/Host-defence peptides ..................................................................... 1 1.2 Defensins................................................................................................................. 1 1.3 β-defensins .............................................................................................................
    [Show full text]
  • Bioinformatics Studies Provide Insight Into Possible Target and Mechanisms of Action of Nobiletin Against Cancer Stem Cells
    DOI:10.31557/APJCP.2020.21.3.611 Bioinformatics Studies Provide Insight into Possible Target and Mechanisms of Action of Nobiletin against Cancer Stem Cells RESEARCH ARTICLE Editorial Process: Submission:05/08/2019 Acceptance:03/06/2020 Bioinformatics Studies Provide Insight into Possible Target and Mechanisms of Action of Nobiletin against Cancer Stem Cells Adam Hermawan1*, Herwandhani Putri2 Abstract Objective: Nobiletin treatment on MDA-MB 231 cells reduces the expression of CXC chemokine receptor type 4 (CXCR4), which is highly expressed in cancer stem cell populations in tumor patients. However, the mechanisms of nobiletin in cancer stem cells (CSCs) remain elusive. This study was aimed to explore the potential target and mechanisms of nobiletin in cancer stem cells using bioinformatics approaches. Methods: Gene expression profiles by public COMPARE predicting the sensitivity of tumor cells to nobiletin. Functional annotations on gene lists are carried out with The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.8, and WEB-based GEne SeT Analysis Toolkit (WebGestalt). The protein-protein interaction (PPI) network was analyzed by STRING-DB and visualized by Cytoscape. Results: Microarray analyses reveal many genes involved in protein binding, transcriptional and translational activity. Pathway enrichment analysis revealed breast cancer regulation of estrogen signaling and Wnt/ß-catenin by nobiletin. Moreover, three hub genes, i.e. ESR1, NCOA3, and RPS6KB1 and one significant module were filtered out and selected from the PPI network. Conclusion: Nobiletin might serve as a lead compound for the development of CSCs-targeted drugs by targeting estrogen and Wnt/ß-catenin signaling. Further studies are needed to explore the full therapeutic potential of nobiletin in cancer stem cells.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0068395 A1 Wood Et Al
    US 2006.0068395A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0068395 A1 Wood et al. (43) Pub. Date: Mar. 30, 2006 (54) SYNTHETIC NUCLEIC ACID MOLECULE (21) Appl. No.: 10/943,508 COMPOSITIONS AND METHODS OF PREPARATION (22) Filed: Sep. 17, 2004 (76) Inventors: Keith V. Wood, Mt. Horeb, WI (US); Publication Classification Monika G. Wood, Mt. Horeb, WI (US); Brian Almond, Fitchburg, WI (51) Int. Cl. (US); Aileen Paguio, Madison, WI CI2O I/68 (2006.01) (US); Frank Fan, Madison, WI (US) C7H 2L/04 (2006.01) (52) U.S. Cl. ........................... 435/6: 435/320.1; 536/23.1 Correspondence Address: SCHWEGMAN, LUNDBERG, WOESSNER & (57) ABSTRACT KLUTH 1600 TCF TOWER A method to prepare synthetic nucleic acid molecules having 121 SOUTHEIGHT STREET reduced inappropriate or unintended transcriptional charac MINNEAPOLIS, MN 55402 (US) teristics when expressed in a particular host cell. Patent Application Publication Mar. 30, 2006 Sheet 1 of 2 US 2006/0068395 A1 Figure 1 Amino Acid Codon Phe UUU, UUC Ser UCU, UCC, UCA, UCG, AGU, AGC Tyr UAU, UAC Cys UGU, UGC Leu UUA, UUG, CUU, CUC, CUA, CUG Trp UGG Pro CCU, CCC, CCA, CCG His CAU, CAC Arg CGU, CGC, CGA, CGG, AGA, AGG Gln CAA, CAG Ile AUU, AUC, AUA Thr ACU, ACC, ACA, ACG ASn AAU, AAC LyS AAA, AAG Met AUG Val GUU, GUC, GUA, GUG Ala GCU, GCC, GCA, GCG Asp GAU, GAC Gly GGU, GGC, GGA, GGG Glu GAA, GAG Patent Application Publication Mar. 30, 2006 Sheet 2 of 2 US 2006/0068395 A1 Spd Sequence pGL4B-4NN3.
    [Show full text]
  • Mapping Cis-Regulatory Chromatin Contacts in Neural Cells Links Neuropsychiatric Disorder Risk Variants to Target Genes
    ARTICLES https://doi.org/10.1038/s41588-019-0472-1 Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes Michael Song1,2, Xiaoyu Yang1, Xingjie Ren1, Lenka Maliskova1, Bingkun Li1, Ian R. Jones1, Chao Wang3, Fadi Jacob4,5,6, Kenneth Wu7, Michela Traglia8, Tsz Wai Tam1, Kirsty Jamieson1, Si-Yao Lu9,10,11, Guo-Li Ming 4,5,12,13,14, Yun Li15,16,17, Jun Yao 9,10,11, Lauren A. Weiss1,8, Jesse R. Dixon 18, Luke M. Judge7,19, Bruce R. Conklin7,20,21, Hongjun Song4,5,12,13,22, Li Gan3,23,24,25 and Yin Shen 1,2,25* Mutations in gene regulatory elements have been associated with a wide range of complex neuropsychiatric disorders. However, due to their cell-type specificity and difficulties in characterizing their regulatory targets, the ability to identify causal genetic variants has remained limited. To address these constraints, we perform an integrative analysis of chromatin interactions, open chromatin regions and transcriptomes using promoter capture Hi-C, assay for transposase-accessible chromatin with high- throughput sequencing (ATAC-seq) and RNA sequencing, respectively, in four functionally distinct neural cell types: induced pluripotent stem cell (iPSC)-induced excitatory neurons and lower motor neurons, iPSC-derived hippocampal dentate gyrus- like neurons and primary astrocytes. We identify hundreds of thousands of long-range cis-interactions between promoters and distal promoter-interacting regions, enabling us to link regulatory elements to their target genes and reveal putative processes that are dysregulated in disease. Finally, we validate several promoter-interacting regions by using clustered regularly inter- spaced short palindromic repeats (CRISPR) techniques in human excitatory neurons, demonstrating that CDK5RAP3, STRAP and DRD2 are transcriptionally regulated by physically linked enhancers.
    [Show full text]
  • What Your Genome Doesn't Tell
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Multi-layered epigenetic control of T cell fate decisions Permalink https://escholarship.org/uc/item/8rs7c7b3 Author Yu, Bingfei Publication Date 2018 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA SAN DIEGO Multi-layered epigenetic control of T cell fate decisions A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Biology by Bingfei Yu Committee in charge: Professor Ananda Goldrath, Chair Professor John Chang Professor Stephen Hedrick Professor Cornelis Murre Professor Wei Wang 2018 Copyright Bingfei Yu, 2018 All rights reserved. The dissertation of Bingfei Yu is approved, and it is ac- ceptable in quality and form for publication on microfilm and electronically: Chair University of California San Diego 2018 iii DEDICATION To my parents who have been giving me countless love, trust and support to make me who I am. iv EPIGRAPH Stay hungary. Stay foolish. | Steve Jobs quoted from the back cover of the 1974 edition of the Whole Earth Catalog v TABLE OF CONTENTS Signature Page.................................. iii Dedication..................................... iv Epigraph.....................................v Table of Contents................................. vi List of Figures.................................. ix Acknowledgements................................x Vita........................................ xii Abstract of
    [Show full text]
  • Loss of the Neural-Specific BAF Subunit ACTL6B Relieves Repression of Early Response Genes and Causes Recessive Autism
    Loss of the neural-specific BAF subunit ACTL6B relieves repression of early response genes and causes recessive autism Wendy Wenderskia,b,c,d, Lu Wange,f,g,1, Andrey Krokhotina,b,c,d,1, Jessica J. Walshh, Hongjie Lid,i, Hirotaka Shojij, Shereen Ghoshe,f,g, Renee D. Georgee,f,g, Erik L. Millera,b,c,d, Laura Eliasa,b,c,d, Mark A. Gillespiek, Esther Y. Sona,b,c,d, Brett T. Staahla,b,c,d, Seung Tae Baeke,f,g, Valentina Stanleye,f,g, Cynthia Moncadaa,b,c,d, Zohar Shiponya,b,c,d, Sara B. Linkerl, Maria C. N. Marchettol, Fred H. Gagel, Dillon Chene,f,g, Tipu Sultanm, Maha S. Zakin, Jeffrey A. Ranishk, Tsuyoshi Miyakawaj, Liqun Luod,i, Robert C. Malenkah, Gerald R. Crabtreea,b,c,d,2, and Joseph G. Gleesone,f,g,2 aDepartment of Pathology, Stanford Medical School, Palo Alto, CA 94305; bDepartment of Genetics, Stanford Medical School, Palo Alto, CA 94305; cDepartment of Developmental Biology, Stanford Medical School, Palo Alto, CA 94305; dHoward Hughes Medical Institute, Stanford University, Palo Alto, CA 94305; eDepartment of Neuroscience, University of California San Diego, La Jolla, CA 92037; fHoward Hughes Medical Institute, University of California San Diego, La Jolla, CA 92037; gRady Children’s Institute of Genomic Medicine, University of California San Diego, La Jolla, CA 92037; hNancy Pritztker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford Medical School, Palo Alto, CA 94305; iDepartment of Biology, Stanford University, Palo Alto, CA 94305; jDivision of Systems Medical Science, Institute for Comprehensive Medical Science, Fujita Health University, 470-1192 Toyoake, Aichi, Japan; kInstitute for Systems Biology, Seattle, WA 98109; lLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037; mDepartment of Pediatric Neurology, Institute of Child Health, Children Hospital Lahore, 54000 Lahore, Pakistan; and nClinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, 12311 Cairo, Egypt Edited by Arthur L.
    [Show full text]
  • Onl Er Msb 145504 GA 1..19
    UC Irvine UC Irvine Previously Published Works Title Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Permalink https://escholarship.org/uc/item/1fz5r77k Journal Molecular systems biology, 11(1) ISSN 1744-4292 Authors Li, Xu Wang, Wenqi Wang, Jiadong et al. Publication Date 2015-01-21 DOI 10.15252/msb.20145504 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Article Proteomic analyses reveal distinct chromatin- associated and soluble transcription factor complexes Xu Li1,†, Wenqi Wang1,†, Jiadong Wang1, Anna Malovannaya2, Yuanxin Xi2,3, Wei Li2,3, Rudy Guerra4, David H Hawke5, Jun Qin2 & Junjie Chen1,* Abstract living organisms. Sophisticated signal transduction pathways are required for the development and survival of any organism, a minor The current knowledge on how transcription factors (TFs), the ulti- disruption of which may cause developmental defects and diseases mate targets and executors of cellular signalling pathways, are such as cancer (Fig 1A). The examples of these highly conserved regulated by protein–protein interactions remains limited. Here, signalling pathways include the Wnt (MacDonald et al,2009),TGF-b we performed proteomics analyses of soluble and chromatin- (Massague, 1998) and NF-jB (Hayden & Ghosh, 2004) pathways. associated complexes of 56 TFs, including the targets of many Many of these pathways function by ultimately regulating the signalling pathways involved in development and cancer, and 37 activity of certain transcription factors (TFs), often by changing their members of the Forkhead box (FOX) TF family. Using tandem affin- localizations. Reports on individual proteins suggested that the ity purification followed by mass spectrometry (TAP/MS), we chromatin association of TFs is tightly controlled by upstream signals.
    [Show full text]
  • The Inflammatory and Normal Transcriptome of Mouse Bladder Detrusor and Mucosa
    Thomas Jefferson University Jefferson Digital Commons Department of Pathology, Anatomy, and Cell Department of Pathology, Anatomy, and Cell Biology Faculty Papers Biology January 2006 The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa Marcia R. Saban University of Oklahoma Helen L. Hellmich University of Texas Mary Turner Oklahoma Medical Research Foundation (OMRF) Ngoc-Bich Nguyen University of Oklahoma and University of Texas Follow this and additional works at: https://jdc.jefferson.edu/pacbfp Rajanikanth Vadigepalli Thomas Part ofJeff theerson Medical Univ Cellersity Biology Commons Let us know how access to this document benefits ouy See next page for additional authors Recommended Citation Saban, Marcia R.; Hellmich, Helen L.; Turner, Mary ; Nguyen, Ngoc-Bich; Vadigepalli, Rajanikanth; Dyer, David W.; Hurst, Robert E.; Centola, Michael; and Saban, Ricardo, "The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa" (2006). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 2. https://jdc.jefferson.edu/pacbfp/2 This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in Department of Pathology, Anatomy, and Cell Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons.
    [Show full text]
  • Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors
    University of Cincinnati Date: 12/20/2010 I, Arturo R Maldonado , hereby submit this original work as part of the requirements for the degree of Doctor of Philosophy in Developmental Biology. It is entitled: Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors Student's name: Arturo R Maldonado This work and its defense approved by: Committee chair: Jeffrey Whitsett Committee member: Timothy Crombleholme, MD Committee member: Dan Wiginton, PhD Committee member: Rhonda Cardin, PhD Committee member: Tim Cripe 1297 Last Printed:1/11/2011 Document Of Defense Form Molecular Targeting and Enhancing Anticancer Efficacy of Oncolytic HSV-1 to Midkine Expressing Tumors A dissertation submitted to the Graduate School of the University of Cincinnati College of Medicine in partial fulfillment of the requirements for the degree of DOCTORATE OF PHILOSOPHY (PH.D.) in the Division of Molecular & Developmental Biology 2010 By Arturo Rafael Maldonado B.A., University of Miami, Coral Gables, Florida June 1993 M.D., New Jersey Medical School, Newark, New Jersey June 1999 Committee Chair: Jeffrey A. Whitsett, M.D. Advisor: Timothy M. Crombleholme, M.D. Timothy P. Cripe, M.D. Ph.D. Dan Wiginton, Ph.D. Rhonda D. Cardin, Ph.D. ABSTRACT Since 1999, cancer has surpassed heart disease as the number one cause of death in the US for people under the age of 85. Malignant Peripheral Nerve Sheath Tumor (MPNST), a common malignancy in patients with Neurofibromatosis, and colorectal cancer are midkine- producing tumors with high mortality rates. In vitro and preclinical xenograft models of MPNST were utilized in this dissertation to study the role of midkine (MDK), a tumor-specific gene over- expressed in these tumors and to test the efficacy of a MDK-transcriptionally targeted oncolytic HSV-1 (oHSV).
    [Show full text]
  • Strong Binding Activity of Few Transcription Factors Is a Major Determinant of Open Chromatin
    bioRxiv preprint doi: https://doi.org/10.1101/204743; this version posted December 12, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Strong binding activity of few transcription factors is a major determinant of open chromatin Bei Wei1, Arttu Jolma1, Biswajyoti Sahu2, Lukas M. Orre3, Fan Zhong1, Fangjie Zhu1, Teemu Kivioja2, Inderpreet Kaur Sur1, Janne Lehtiö3, Minna Taipale1 and Jussi Taipale1,2,4* 1Division of Functional Genomics and Systems Biology, Department of Medical Biochemistry and Biophysics, and Department of Biosciences and Nutrition, Karolinska Institutet, SE 141 83, Stockholm, Sweden 2Genome-Scale Biology Program, P.O. Box 63, FI-00014 University of Helsinki, Finland 3Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, SE 141 83, Stockholm, Sweden 4Department of Biochemistry, University of Cambridge, United Kingdom *To whom correspondence should be addressed. E-mail: [email protected] Abstract It is well established that transcription factors (TFs) play crucial roles in determining cell identity, and that a large fraction of all TFs are expressed in most cell types. In order to globally characterize activities of TFs in cells, we have developed a novel massively parallel protein activity assay, Active TF Identification (ATI) that measures DNA-binding activity of all TFs from any species or tissue type. In contrast to previous studies based on mRNA expression or protein abundance, we found that a set of TFs binding to only around ten distinct motifs display strong DNA-binding activity in any given cell or tissue type.
    [Show full text]
  • PDF-Document
    Supplementary Material Investigating the role of microRNA and Transcription Factor co-regulatory networks in Multiple Sclerosis pathogenesis Nicoletta Nuzziello1, Laura Vilardo2, Paride Pelucchi2, Arianna Consiglio1, Sabino Liuni1, Maria Trojano3 and Maria Liguori1* 1National Research Council, Institute of Biomedical Technologies, Bari Unit, Bari, Italy 2National Research Council, Institute of Biomedical Technologies, Segrate Unit, Milan, Italy 3Department of Basic Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy Supplementary Figure S1 Frequencies of GO terms and canonical pathways. (a) Histogram illustrates the GO terms associated to assembled sub-networks. (b) Histogram illustrates the canonical pathways associated to assembled sub-network. a b Legends for Supplementary Tables Supplementary Table S1 List of feedback (FBL) and feed-forward (FFL) loops in miRNA-TF co-regulatory network. Supplementary Table S2 List of significantly (adj p-value < 0.05) GO-term involved in MS. The first column (from the left) listed the GO-term (biological processes) involved in MS. For each functional class, the main attributes (gene count, p-value, adjusted p-value of the enriched terms for multiple testing using the Benjamini correction) have been detailed. In the last column (on the right), we summarized the target genes involved in each enriched GO-term. Supplementary Table S3 List of significantly (adj p-value < 0.05) enriched pathway involved in MS. The first column (from the left) listed the enriched pathway involved in MS. For each pathway, the main attributes (gene count, p-value, adjusted p-value of the enriched terms for multiple testing using the Benjamini correction) have been detailed. In the last column (on the right), we summarized the target genes involved in each enriched pathway.
    [Show full text]
  • Bioinformatics Network Analyses of Growth
    Bioinformatics Network Analyses of Growth differentiation factor 11 anti-aging study Feng Zhang 1, 2, 3, 4, 5, Xia Yang 4 *, Zhijun Bao 1, 2, 3 * 1 Huadong Hospital Affiliated to Fudan University, 221 West Yan an Road, Shanghai, 200040, China. 2 National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, 12 Mid Urumqi Road, Shanghai, 200040, China. 3 Shanghai Key Laboratory of Clinical Geriatric Medicine, 221 West Yan an Road, Shanghai, 200040, China. 4 Department of Integrative Biology and Physiology, University of California, Los Angeles, 610 Charles E. Young Dr. E, Terasaki Life Sciences Bldg. Rm 2000B, Los Angeles, CA90095, USA. 5 Department of Geriatrics, Huashan Hospital Affiliated to Fudan University, 12 Mid Urumqi Road, Shanghai, 200040, China. * These authors contributed equally to this work. 1 Supplementary Information Supplementary Table S1 GDF11 Genetic Co-expression Module Number of Each Human Tissue Tissue Module Amount Adipose Visceral omentum 1 Nervous System Cerebellum 1 Cerebellar hemisphere 1 Frontal cortex 1 Hippocampus 1 Nerve tibialis 1 Cardiovascular System Left ventricle 1 Digestive System Esophagus mucosa 1 Esophagus muscle 1 Stomach 1 Small intestine terminal ileum 1 Colon transverse 1 Colon sigmoid 1 Liver 1 Skeletal Muscle 1 Lung 1 Kidney 1 Endocrine System Pituitary 1 Thyroid 1 Adrenal gland 1 Female Reproduction Ovary 1 System Male Reproduction Testis 1 System Prostate 1 Total 23 2 Supplementary Table S2 Pathways and Functions of GDF11 Gene Co-expression Networks of Human
    [Show full text]